Boule Con-Diff Hematology Control For in vitro diagnostic use as a control to monitor the performance of multi-parameter hematology instruments.
Published November 14, 2012 · Recall initiated: March 24, 2011
Summary
FDA records medical device Class III recall Z-0191-2013, published November 14, 2012 and initiated March 24, 2011. Recalling firm: Clinical Diagnostic Solutions; Status: Terminated; Reported quantity: 197 vials; Lot: Product Part 502-012, Lot #1102-574. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Clinical Diagnostic Solutions, Inc. in Plantation, FL recalled Boule Con Diff US Tri Pack (Product Part 501-605, Lot #1102-575 and 1102-576; Product Part 501-607, Lot #1102-576; and Product Part 502-012, Lot #1102-574) which is used for in vitro diagnostic use as a control to monitor the performance of multi-parameter hematology instruments. The recall was initiated due to the receipt of a complai
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Clinical Diagnostic Solutions
- Distributor
- Worldwide Distribution - USA including AL, AR, AZ, CA, CO, DE, FL, GA, IA, IL, IN, KY, LA, MA, MD, MI, MS, ND, ND, NE, NJ, NY, OH, OK, PA, SC, TN, TX, UT, VA, WI, WV,and WY. Foreign: Brazil and Colombia
- Lot
- Product Part 502-012, Lot #1102-574
- Risk classification
- Class III
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDABoule Con-Diff Tri-Level Multi-Parameter Assayed Hematology Control, used for in vitro diagnostic use as aApril 16, 2014
- FDABoule Con Diff US Tri Pack, 6 Vials. For in vitro diagnostic use as a control to monitor the performance ofNovember 14, 2012
- FDABoule Con-Diff Hematology Control 9 vials. For in vitro diagnostic use as a control to monitor the performanceNovember 14, 2012
- FDABoule Con-Diff Hematology Control For in vitro diagnostic use as a control to monitor the performance ofNovember 14, 2012
- FDABoule Con-Diff Hematology Control For in vitro diagnostic use as a control to monitor the performance ofNovember 14, 2012
- FDACliniqa Liquid QCTM Cardiac Marker Control for i-STAT Level 1 (List Number 06F12-09; Lot Number 071039)November 14, 2012
Questions about this recall
Was Boule Con-Diff Hematology Control For in vitro diagnostic use as a control to monitor the performance of multi-parameter hematology instruments. recalled?
Yes. FDA published recall Z-0191-2013 on November 14, 2012. Reported hazard: Clinical Diagnostic Solutions, Inc. in Plantation, FL recalled Boule Con Diff US Tri Pack (Product Part 501-605, Lot #1102-575 and 1102-576; Product Part 501-607, Lot #1102-576; and Product Part 502-012, Lot #1102-574) which is used for in vitro diagnostic use as a control to monitor the performance of multi-parameter hematology instruments. The recall was initiated due to the receipt of a complai
What should I do if I have this product?
Voluntary: Firm initiated · Letter